Advertisement

Breast Cancer

, Volume 21, Issue 4, pp 415–422 | Cite as

Feasibility of intraoperative radiation therapy for early breast cancer in Japan: a single-center pilot study and literature review

  • Masataka SawakiEmail author
  • Naoto Kondo
  • Akiyo Horio
  • Aya Ushio
  • Naomi Gondo
  • Eri Adachi
  • Masaya Hattori
  • Takashi Fujita
  • Hiroyuki Tachibana
  • Takeshi Kodaira
  • Hiroji Iwata
Original Article

Abstract

Background

Intraoperative radiation therapy (IORT) is under evaluation in breast-conserving surgery because the feasibility of the IORT procedure including transportation of the patient under general anesthesia is not well established. Thus, this prospective single-center study aimed to test the feasibility of IORT at a single dose of 21 Gy in Japanese breast cancer patients.

Methods

The primary endpoint was early toxicity; the secondary endpoint was late toxicity. Patients with histologically or cytologically proven primary early breast cancer were eligible. Inclusion criteria were as follows: (1) T < 2.5 cm; (2) desire for breast-conserving surgery; (3) age >50 years; (4) surgical margin >1 cm; (5) intraoperative pathologically free margins; and (6) sentinel node negative. Exclusion criteria were (1) contraindications to radiation therapy; (2) past radiation therapy for the same breast or chest; (3) extensive intraductal component; and (4) a tumor located in the axillary tail of the breast. All patients gave written informed consent. Partial resection was performed with at least a margin of 1 cm around the tumor. The patient was transported from the surgical suite to the radiation room. Radiation (Clinac® 21EX, Varian Medical Systems, Inc.) at 21 Gy was delivered directly to the mammary gland. Toxicity was evaluated with the Common Terminology Criteria for Adverse Events V4.0.

Results

Five patients were enrolled in this pilot study and received 21 Gy. Follow-up ranged from 7.8 to 11.0 months (median 10.2). Intraoperative transportation to the radiation room during the surgical procedure under general anesthesia was performed safely in all patients. Treatment-related toxicities within 3 months were deep connective tissue fibrosis (grade 1, n = 3) and pain (grade 1, n = 3). There was no case of wound infection, wound dehiscence, or soft tissue necrosis. Overall, there was no severe adverse event.

Conclusions

The procedure was tolerated very well in this first group of Japanese female patients treated with IORT, as was the case with European women. A longer follow-up is needed for the evaluation of any potential late side effects or recurrences. A phase II study is now being conducted for the next group of patients (UMIN000003578).

Keywords

Breast cancer Intraoperative radiotherapy Early breast cancer 

Abbreviations

ALND

Axillary lymph node dissection

APBI

Accelerated partial breast irradiation

ASTRO

American Society for Therapeutic Radiation Oncology

BCT

Breast-conserving therapy

DCIS

Ductal carcinoma in situ

EBRT

External beam radiation

EIC

Extensive intraductal component

ELIOT

Electron intraoperative therapy

ER

Estrogen receptor

IORT

Intraoperative radiotherapy

LCIS

Lobular carcinoma in situ

LVSI

Lymph-vascular space invasion

PBI

Partial breast irradiation

PMMA

Polymethyl methacrylate

RT

Radiotherapy

SN Bx

Sentinel lymph node biopsy

TARGIT

Targeted intraoperative radiotherapy

WBI

Whole breast external irradiation therapy

Notes

Acknowledgments

This research was funded in part by the Japanese Foundation for Multidisciplinary Treatment of Cancer.

Conflict of interest

The authors state that they have no conflict of interest.

References

  1. 1.
    Veronesi U, Cascinelli N, Mariani L, Greco M, Saccozzi R, Luini A, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002;347:1227–32.PubMedCrossRefGoogle Scholar
  2. 2.
    Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347:1233–41.PubMedCrossRefGoogle Scholar
  3. 3.
    Clarke M, Collins R, Darby S, Davies C, Elphinstone P, Evans E, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;366:2087–106.PubMedCrossRefGoogle Scholar
  4. 4.
    Darby S, McGale P, Correa C, Taylor C, Arriagada R, Clarke M, et al. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet. 2011;378:1707–16.PubMedCrossRefGoogle Scholar
  5. 5.
    Njeh CF, Saunders MW, Langton CM. Accelerated partial breast irradiation (APBI): a review of available techniques. Radiat Oncol. 2010;5.Google Scholar
  6. 6.
    Skandarajah AR, Lynch AC, Mackay JR, Ngan S, Heriot AG. The role of intraoperative radiotherapy in solid tumors. Ann Surg Oncol. 2009;16:735–44.PubMedCrossRefGoogle Scholar
  7. 7.
    Veronesi U, Orecchia R, Luini A, Gatti G, Intra M, Zurrida S, et al. A preliminary report of intraoperative radiotherapy (IORT) in limited-stage breast cancers that are conservatively treated. Eur J Cancer. 2001;37:2178–83.PubMedCrossRefGoogle Scholar
  8. 8.
    Luini A, Orecchia R, Gatti G, Intra M, Ciocca M, Galimberti V, et al. The pilot trial on intraoperative radiotherapy with electrons (ELIOT): update on the results. Breast Cancer Res Treat. 2005;93:55–9.PubMedCrossRefGoogle Scholar
  9. 9.
    Veronesi U, Orecchia R, Luini A, Galimberti V, Gatti G, Intra M, et al. Full-dose intraoperative radiotherapy with electrons during breast-conserving surgery. Ann Surg. 2005;242:101–6.PubMedCentralPubMedCrossRefGoogle Scholar
  10. 10.
    Intra M, Luini A, Gatti G, Ciocca M, Gentilini O, Viana A, et al. Surgical technique of intraoperative radiation therapy with electrons (ELIOT) in breast cancer: a lesson learned by over 1000 procedures. Surgery. 2006;140:467–71.PubMedCrossRefGoogle Scholar
  11. 11.
    Veronesi U, Orecchia R, Luini A, Galimberti V, Zurrida S, Intra M, et al. Intraoperative radiotherapy during breast conserving surgery: a study on 1,822 cases treated with electrons. Breast Cancer Res Treat. 2010;124:141–51.PubMedCrossRefGoogle Scholar
  12. 12.
    Sawaki M, Sato S, Kikumori T, Ishihara S, Aoyama Y, Itoh Y, et al. A phase I study of intraoperative radiotherapy for early breast cancer in Japan. World J Surg. 2009;33:2587–92.PubMedCrossRefGoogle Scholar
  13. 13.
    Sawaki M, Sato S, Noda S, Idota A, Uchida H, Tsunoda N, et al. Phase I/II study of intraoperative radiotherapy for early breast cancer in Japan. Breast Cancer. 2011. doi: 10.1007/s12282-011-0294-1.
  14. 14.
    Oshima T, Aoyama Y, Shimozato T, Sawaki M, Imai T, Ito Y, et al. An experimental attenuation plate to improve the dose distribution in intraoperative electron beam radiotherapy for breast cancer. Phys Med Biol. 2009;54:3491–500.PubMedCrossRefGoogle Scholar
  15. 15.
    Vicini F, Arthur D, Wazer D, Chen P, Mitchell C, Wallace M, et al. Limitations of the American Society of Therapeutic Radiology and Oncology Consensus Panel guidelines on the use of accelerated partial breast irradiation. Int J Radiat Oncol Biol Phys. 2011;79:977–84.PubMedCrossRefGoogle Scholar
  16. 16.
    Polgár C, Limbergen EV, Pötter R, Kovács G, Polo A, Lyczek J, et al. Patient selection for accelerated partial-breast irradiation (APBI) after breast-conserving surgery: recommendations of the Groupe Européen de Curiethérapie-European Society for Therapeutic Radiology and Oncology (GEC-ESTRO) breast cancer working group based on clinical evidence (2009). Radiother Oncol. 2010;94:264–73.PubMedCrossRefGoogle Scholar
  17. 17.
    Orecchia R, Ivaldi GB, Leonardi MC. Integrated breast conservation and intraoperative radiation therapy. Breast. 2009;18(Suppl 3):S98–102.PubMedCrossRefGoogle Scholar
  18. 18.
    Veronesi U, Marubini E, Mariani L, Galimberti V, Luini A, Veronesi P, et al. Radiotherapy after breast-conserving surgery in small breast carcinoma: long-term results of a randomized trial. Ann Oncol. 2001;12:997–1003.PubMedCrossRefGoogle Scholar
  19. 19.
    Vicini FA, Kestin L, Chen P, Benitez P, Goldstein NS, Martinez A. Limited-field radiation therapy in the management of early-stage breast cancer. JNCI J Nat Cancer Inst. 2003;95:1205–10.CrossRefGoogle Scholar
  20. 20.
    Benitez P, Keisch M, Vicini F, Stolier A, Scroggins T, Walker A, et al. Five-year results: the initial clinical trial of Mammosite balloon brachytherapy for partial breast irradiation in early-stage breast cancer. Am J Surg. 2007;194:456–62.PubMedCrossRefGoogle Scholar
  21. 21.
    Vicini FA, Baglan KL, Kestin LL, Mitchell C, Chen PY, Frazier RC, et al. Accelerated treatment of breast cancer. J Clin Oncol. 2001;19:1993–2001.PubMedGoogle Scholar
  22. 22.
    Antonucci JV, Wallace M, Goldstein NS, Kestin L, Chen P, Benitez P, et al. Differences in patterns of failure in patients treated with accelerated partial breast irradiation versus whole-breast irradiation: a matched-pair analysis with 10-year follow-up. Int J Radiat Oncol Biol Phys. 2009;74:447–52.PubMedCrossRefGoogle Scholar
  23. 23.
    Park CC, Mitsumori M, Nixon A, Recht A, Connolly J, Gelman R, et al. Outcome at 8 years after breast-conserving surgery and radiation therapy for invasive breast cancer: influence of margin status and systemic therapy on local recurrence. J Clin Oncol. 2000;18:1668–75.PubMedGoogle Scholar
  24. 24.
    Fisher ER. Lumpectomy margins and much more. Cancer. 1997;79:1453–8 (discussion 9–60).Google Scholar
  25. 25.
    Smith BD, Arthur DW, Buchholz TA, Haffty BG, Hahn CA, Hardenbergh PH, et al. Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO). J Am Coll Surg. 2009;209:269–77.PubMedCrossRefGoogle Scholar
  26. 26.
    Bartelink H, Horiot JC, Poortmans PM, Struikmans H, Van den Bogaert W, Fourquet A, et al. Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial. J Clin Oncol. 2007;25:3259–65.PubMedCrossRefGoogle Scholar
  27. 27.
    Antonini N, Jones H, Horiot JC, Poortmans P, Struikmans H, Van den Bogaert W, et al. Effect of age and radiation dose on local control after breast conserving treatment: EORTC trial 22881-10882. Radiother Oncol. 2007;82:265–71.PubMedCrossRefGoogle Scholar
  28. 28.
    Chao KK, Vicini FA, Wallace M, Mitchell C, Chen P, Ghilezan M, et al. Analysis of treatment efficacy, cosmesis, and toxicity using the MammoSite breast brachytherapy catheter to deliver accelerated partial-breast irradiation: the William Beaumont Hospital experience. Int J Radiat Oncol Biol Phys. 2007;69:32–40.PubMedCrossRefGoogle Scholar
  29. 29.
    Smith BD, Arthur DW, Buchholz TA, Haffty BG, Hahn CA, Hardenbergh PH, et al. Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO). Int J Radiat Oncol Biol Phys. 2009;74:987–1001.PubMedCrossRefGoogle Scholar
  30. 30.
    Al-Hallaq HA, Mell LK, Bradley JA, Chen LF, Ali AN, Weichselbaum RR, et al. Magnetic resonance imaging identifies multifocal and multicentric disease in breast cancer patients who are eligible for partial breast irradiation. Cancer. 2008;113:2408–14.PubMedCrossRefGoogle Scholar
  31. 31.
    Tendulkar RD, Chellman-Jeffers M, Rybicki LA, Rim A, Kotwal A, Macklis R, et al. Preoperative breast magnetic resonance imaging in early breast cancer: implications for partial breast irradiation. Cancer. 2009;115:1621–30.PubMedCrossRefGoogle Scholar
  32. 32.
    Houssami N, Ciatto S, Macaskill P, Lord SJ, Warren RM, Dixon JM, et al. Accuracy and surgical impact of magnetic resonance imaging in breast cancer staging: systematic review and meta-analysis in detection of multifocal and multicentric cancer. J Clin Oncol. 2008;26:3248–58.PubMedCrossRefGoogle Scholar
  33. 33.
    Turnbull L, Brown S, Harvey I, Olivier C, Drew P, Napp V, et al. Comparative effectiveness of MRI in breast cancer (COMICE) trial: a randomised controlled trial. Lancet. 2010;375:563–71.PubMedCrossRefGoogle Scholar
  34. 34.
    Orecchia R, Leonardo MC. Intraoperative radiation therapy: is it a standard now? Breast. 2011;20(Suppl 3):S111–5.PubMedCrossRefGoogle Scholar
  35. 35.
    Beal K, McCormick B, Zelefsky M, Borgen P, Fey J, Goldberg J, et al. Single-fraction intraoperative radiotherapy for breast cancer: early cosmetic results. Int J Radiat Oncol Biol Phys. 2007;69:19–24.PubMedCrossRefGoogle Scholar
  36. 36.
    Chism D, Freedman G, Li T, Anderson P. Re-excision of margins before breast radiation—diagnostic or therapeutic? Int J Radiat Oncol Biol Phys. 2006;65:1416–21.PubMedCrossRefGoogle Scholar
  37. 37.
    Mariani L, Salvadori B, Marubini E, Conti AR, Rovini D, Cusumano F, et al. Ten year results of a randomised trial comparing two conservative treatment strategies for small size breast cancer. Eur J Cancer. 1998;34:1156–62.PubMedCrossRefGoogle Scholar
  38. 38.
    Fukamachi K, Ishida T, Usami S, Takeda M, Watanabe M, Sasano H, et al. Total-circumference intraoperative frozen section analysis reduces margin-positive rate in breast-conservation surgery. Jpn J Clin Oncol. 2010;40:513–20.PubMedCrossRefGoogle Scholar
  39. 39.
    Kyndi M, Sorensen FB, Knudsen H, Overgaard M, Nielsen HM, Overgaard J. Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: the Danish Breast Cancer Cooperative Group. J Clin Oncol. 2008;26:1419–26.PubMedCrossRefGoogle Scholar
  40. 40.
    Nguyen PL, Taghian AG, Katz MS, Niemierko A, Abi Raad RF, Boon WL, et al. Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy. J Clin Oncol. 2008;26:2373–8.PubMedCrossRefGoogle Scholar
  41. 41.
    Solin LJ. Tailored local-regional treatment for early-stage breast cancer. Clin Breast Cancer. 2010;10:343–4.PubMedCrossRefGoogle Scholar
  42. 42.
    Haffty BG, Vicini FA, Beitsch P, Quiet C, Keleher A, Garcia D, et al. Timing of chemotherapy after MammoSite radiation therapy system breast brachytherapy: analysis of the American Society of Breast Surgeons MammoSite breast brachytherapy registry trial. Int J Radiat Oncol Biol Phys. 2008;72:1441–8.PubMedCrossRefGoogle Scholar
  43. 43.
    Buchholz TA. Radiation therapy for early-stage breast cancer after breast-conserving surgery. N Engl J Med. 2009;360:63–70.PubMedCrossRefGoogle Scholar
  44. 44.
    Rampinelli C, Bellomi M, Ivaldi GB, Intra M, Raimondi S, Meroni S, et al. Assessment of pulmonary fibrosis after radiotherapy (RT) in breast conserving surgery: comparison between conventional external beam RT (EBRT) and intraoperative RT with electrons (ELIOT). Technol Cancer Res Treat. 2011;10:323–9.PubMedGoogle Scholar

Copyright information

© The Japanese Breast Cancer Society 2012

Authors and Affiliations

  • Masataka Sawaki
    • 1
    Email author
  • Naoto Kondo
    • 1
  • Akiyo Horio
    • 1
  • Aya Ushio
    • 1
  • Naomi Gondo
    • 1
  • Eri Adachi
    • 1
  • Masaya Hattori
    • 1
  • Takashi Fujita
    • 1
  • Hiroyuki Tachibana
    • 2
  • Takeshi Kodaira
    • 2
  • Hiroji Iwata
    • 1
  1. 1.Department of Breast OncologyAichi Cancer Center HospitalNagoyaJapan
  2. 2.Department of Radiation OncologyAichi Cancer Center HospitalNagoyaJapan

Personalised recommendations